Abstract
In 2010, Brazil was the first country to introduce the 10-valent pneumococcal conjugate vaccine (PCV10) into a national immunization program for children under 2 years of age. It is well documented that introduction of PCVs has resulted in a shift in the epidemiology of the invasive pneumococcal disease (IPD). The selective pressure exerted by the vaccine resulted in the replacement of se…